Last reviewed · How we verify

NCT03184623

Muscle Mass and Body Composition

Completed Last updated 8 September 2017
What this trial tests

trial testing muscle mass measurement in Muscle Loss in 23 participants. Completed in 5 September 2017.

Timeline
9 June 2017
Primary endpoint
5 September 2017
5 September 2017

Quick facts

Lead sponsorFrisius Medisch Centrum
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date9 June 2017
Primary completion5 September 2017
Estimated completion5 September 2017
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Frisius Medisch Centrum — full company profile →

Who can join

18 and older, any sex, with Muscle Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ICUacquired weakness is a common complication of critical illness, particularly in patients receiving mechanical ventilation and/or suffering from conditions leading to the systemic inflammatory response syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Muscle Loss

Currently open trials in the same condition.

Other Frisius Medisch Centrum trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03184623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing